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Clinical and Research Needs
In addition to the development of functional
tissue equivalents, tissue engineering holds
the promise of revolutionizing the
pharmacological industry by providing novel
venues for high throughput drug testing.
Research Approach
Utilize tissue engineering methods to
develop functional tissue equivalents,
via optimization of cell sourcing and
engineering of the tissue culture
microenvironment in terms of ECM
composition and growth factor milieu.
1.Cell Sourcing: Testing various stem
cell populations including embryonic
stem cells, fetal cells, and adult stem
cells.
2.Scaffold Engineering: Design and
implement extracellular matrix scaffolds
that support optimal tissue
development.
3.Growth Factor Biology: Optimize the
growth factor stimulation required to
stimulate functional tissue
development.
Deliverables
1. High throughput systems for drug
development and screening as well as
patient specific gene expression profiling
and pharmacogenomics.
2. Therapeutic translation of
engineered tissues, i.e. surgical
implantation.
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Goals
1. Generate functional tissue equivalents.
2. Demonstrate physiological responses.
3. Induce pathological conditions.
4. Test therapeutics in disease models.
Functional Lung Tissue Constructs
Epithelial Branching
Morphogenesis
Vascularization
High Throughput Drug Screening
Process Scale Up:96-well plate format
Physiological Responses
-surfactant production
and secretion
Pathological Responses
Potential Models of pulmonary disease:
1.Pulmonary hypertension models, i.e. chronic
hypoxia, can be generated by culturing lung tissue
constructs under chronic hypoxic conditions.
2.Emphysema disease models can be generated by
exposing lung constructs to known destructive
agents.
Therapeutic Testing
-utilize engineered physiological
and disease condition models to
accelerate drug development.
Optimization
We must engineer these constructs to reflect both the
organotypic lung architecture and differentiative status
of the lung alveolus. Upon development of a suitable
construct, the potential is vast for application in the
realms of clinical medicine and drug development.
In such a system, a large number of compounds
could be tested in suitable replicates in parallel.
This is of great need due to the laborious and
variable nature of animal experiments and inability
of standard cell culture models to approximate
either normal or disease tissue conditions.
Outcome Parameters:
-Biochemical tests for changes in cellular
metabolism, proliferation, apoptosis, etc.
-Genomic/Proteomic profiling to examine global
changes in cellular physiology in response to
molecular stimuli.
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